CXCL13 and primary progressive multiple sclerosis: Few reports have demonstrated cytokine/chemokine increases in the CSF of PPMS patients such as CXCL13, a B cell chemoattractant [41], IL-10, an anti-inflammatory cytokine [42], and TNF-α [42].